Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Cash from Investing Activities (2023 - 2025)

Bioregenx (BRGX) has 3 years of Cash from Investing Activities data on record, last reported at -$6000.0 in Q3 2025.

  • For Q3 2025, Cash from Investing Activities changed N/A year-over-year to -$6000.0; the TTM value through Sep 2025 reached -$53348.0, up 86.32%, while the annual FY2024 figure was -$187945.0, 5.73% up from the prior year.
  • Cash from Investing Activities reached -$6000.0 in Q3 2025 per BRGX's latest filing, up from -$50000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2652.0 in Q4 2024 and bottomed at -$199363.0 in Q4 2023.
  • Average Cash from Investing Activities over 3 years is -$88661.6, with a median of -$50000.0 recorded in 2025.
  • The widest YoY moves for Cash from Investing Activities: up 101.33% in 2024, down 101.33% in 2024.
  • A 3-year view of Cash from Investing Activities shows it stood at -$199363.0 in 2023, then surged by 101.33% to $2652.0 in 2024, then tumbled by 326.24% to -$6000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$6000.0 in Q3 2025, -$50000.0 in Q2 2025, and $2652.0 in Q4 2024.